Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 24 Issue 3, March 2018

The ability of macrophages to integrate metabolic and immune signaling is a key determinant of atherogenesis. Sallam et al. (p 304) report the identification of a non-coding RNAs, MeXis, that coordinates cellular responses to cholesterol overload in macrophages and lesion development. The cover image is a scanning electron micrograph depicting a dying cholesterol-loaded macrophage with cholesterol crystals piercing the cell and extending from the cell surface. Image Credit: Thomas Weston, Cuiwen He and Stephen G Young, UCLA.

Editorial

  • Therapies for Alzheimer's disease and other neurodegenerative diseases are desperately needed. Yet, a string of disappointments in the neurodegenerative therapy space has meant that several companies over the years have ended their investment in the field. Some companies have diversified their research and development (R&D) models to hedge their bets. Maintaining this diversity to bring down the silos between big pharma and smaller research teams may be necessary to jumpstart and sustain progress in combatting neurodegenerative conditions.

    Nature Outlook:

    Editorial

    Advertisement

Top of page ⤴

News Feature

Top of page ⤴

News & Views

  • Studies in metastatic melanoma, non-small-cell lung carcinoma and renal cell carcinoma indicate certain bacteria within the gut microbiota enhance clinical responses to checkpoint blockade.

    • Cynthia L Sears
    • Drew M Pardoll
    News & Views
  • In a nonhuman primate model of Zika virus infection, structural and cellular pathology deficits that could have a long-lasting impact on neural development and neurocognitive function are detected in offspring of infected mothers.

    • Kimberly M Christian
    • Hongjun Song
    • Guo-li Ming
    News & Views
  • An active immunosuppressive pathway is identified in colon cancer that confers immune evasion by the cancer and can be targeted to synergize with immunotherapies.

    • Antoine Marçais
    • Thierry Walzer
    News & Views
Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Search

Quick links